Mounjaro (Tirzepatide) NDC 0002-1152

Product information

Brand name (proprietary)

Mounjaro

Generic name (nonproprietary)

tirzepatide

Active ingredients

Tirzepatide — 2.5 mg/.5mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

Eli Lilly and CompanyNDC labeler code 0002

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 215866

Marketing start

Jul 28, 2023

Listing expires

Dec 31, 2027

Other FDA classes

G-Protein-linked Receptor Interactions (Mechanism)Glucagon-like Peptide-1 (GLP-1) Agonists (Mechanism)

Identifiers

Product ID 0002-1152_8f6367b6-bf0d-46e1-ba7d-0417523474e5SPL ID 8f6367b6-bf0d-46e1-ba7d-0417523474e5SPL set ID d2d7da5d-ad07-4228-955f-cf7e355c8cc0RxCUI 2601743, 2601746, 2601755, 2601758, 2601761, 2601764, 2601767, 2601770, 2601773, 2601776, 2601784, 2601785, 2644396, 2644399, 2644401, 2644403, 2644405, 2644407, 2644409, 2644411, 2644413, 2644415, 2644417, 2644419, 2732437, 2732442, 2732446, 2732449, 2732452, 2732456, 2733666, 2733668, 2733670, 2733671, 2733673, 2733675, 2734623, 2734628, 2734632, 2734636, 2734640, 2734644, 2735286, 2735288, 2735290, 2735292, 2735294, 2735297UNII OYN3CCI6QEUPC 0300023002013, 0300021152017, 0300022423017, 0300024612112, 0300024052116, 0300024304116, 0300021243012, 0300024523111

Pharmacologic class

GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

No drug-specific HCPCS code in Med-Code’s directory for this product.

Med-Code's directory has no drug-specific HCPCS code for Mounjaro. It is usually self-administered and billed by NDC through a pharmacy benefit.

If a payer accepts an unclassified code for it in a clinical setting, that would be J3490 (Unclassified drugs), with the NDC, quantity and often the invoice. Acceptance varies by payer.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002115201 followed by a unit qualifier and the quantity Copy

Package 00002-1152-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

About NDC 0002-1152

What is NDC 0002-1152?

0002-1152 is the product NDC for Mounjaro (tirzepatide), Tirzepatide 2.5 mg/.5mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Mounjaro (Tirzepatide).

What is the active ingredient?

Tirzepatide.

Who is the labeler?

Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mounjaro?

23 other product NDCs are listed under this name. See all Mounjaro NDCs.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory. See Billing references above.

Related NDCs: other Mounjaro products

Other finished products listed under the same name: strengths, forms and labelers.

All 24 Mounjaro NDCs

Other NDCs under NDA 215866

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 29.